Here are four things to know:
1. The patent issued is entitled “Apparatus and Methods for Rehabilitating a Muscle And Assessing Progress of Rehabilitation.”
2. The patent was issued in related to its ReActiv8 system.
3. The system is an implantable neurostimulation system designed to treat disabling chronic low back pain.
4. Mainstay Medical is a medical device company headquartered in Dublin, Ireland. It also has subsidiaries operating in Ireland, the United States and Australia.
More articles on devices:
Xtant Medical receives FDA clearance for demineralized bone matrix putty: 4 observations
Wireless sensors in orthopedic implants may detect SSIs — 4 things to know
Prosthetic market faces reimbursement challenges — 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
